Antifibrinolytic agent tranexamic acid for nasal haemorrhage (epistaxis)

To determine the effectiveness of tranexamic acid compared with placebo or no additional intervention in the management of patients with epistaxis.

To compare the morbidity and mortality associated with tranexamic acid with that associated with placebo or 'usual care'.

This is a protocol.